Hugh Zhao

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 253 citations · Full text

Medicine, Oncology, Pharmacology +9

Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist

Paweł Dobrzański, Kathryn Hunter, Susan Jones‐Bolin et al. · Cancer Research · 2004 · 160 citations

Medicine, Oncology, Pharmacology +13

Late Stent Expansion and Neointimal Proliferation of Oversized Nitinol Stents in Peripheral Arteries

Hugh Zhao, Alexander Nikanorov, Renu Virmani et al. · CardioVascular and Interventional Radiology · 2009 · 107 citations · Full text

Medicine, Cardiology, Surgery +16

Idoxifene: A Novel Selective Estrogen Receptor Modulator Prevents Bone Loss and Lowers Cholesterol Levels in Ovariectomized Rats and Decreases Uterine Weight in Intact Rats

Mark Nuttall, Jeremy N. Bradbeer, George B. Stroup et al. · Endocrinology · 1998 · 88 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Mechanisms of Tissue Uptake and Retention in Zotarolimus-Coated Balloon Therapy

Vijaya B. Kolachalama, Stephen Pacetti, Joseph W. Franses et al. · Circulation · 2013 · 81 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17